News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News ACC 2021 Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients Shelley Wood May 16, 2021
News Daily News No Long-term CV Impact With Mild COVID-19, Two New Studies Reassure L.A. McKeown May 12, 2021
News Conference News ACC 2021 Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients Caitlin E. Cox May 07, 2021
News Daily News USPSTF Reaffirms Earlier Stance on Hypertension Screening in Adults L.A. McKeown April 28, 2021
News Daily News Assessing Myocardial Damage in COVID-19: The Role of CMR Todd Neale February 19, 2021
News Daily News Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients Michael O'Riordan February 15, 2021
News Daily News Rivaroxaban May Yet Protect After a Hospital Stay: MARINER Caitlin E. Cox June 25, 2020